Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Weissmann

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|January 20, 2022
Low-Dose Radiotherapy Leads to a Systemic Anti-Inflammatory Shift in the Pre-Clinical K/BxN Serum Transfer Model and Reduces Osteoarthritic Pain in PatientsThomas Weissmann, Michael Rückert, Jian-Guo Zhou, et al.
Cells|February 25, 2022
Radon Improves Clinical Response in an Animal Model of Rheumatoid Arthritis Accompanied by Increased Numbers of Peripheral Blood B Cells and Interleukin-5 ConcentrationLisa Deloch, Stephanie Hehlgans, Michael Rückert, et al.
Cancers|April 3, 2021
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal CancerOliver J Ott, Cihan Gani, Lars H Lindner, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 23, 2023
Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease controlAlexander Willner, Abbas Agaimy, Katja Fechner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 5, 2023
Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects-challenges for future studiesThomas Weissmann, Michael Rückert, Florian Putz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 25, 2020
Magnetic resonance imaging for brain stereotactic radiotherapy : A review of requirements and pitfallsFlorian Putz, Veit Mengling, Rosalind Perrin, et al.
BMC Cancer|March 25, 2021
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitorsLuisa Maria Griewing, Claudia Schweizer, Philipp Schubert, et al.
Frontiers in Oncology|January 22, 2026
Correction: Benchmarking GPT-5 in radiation oncology: measurable gains, but persistent need for expert oversightUgur Dinç, Jibak Sarkar, Philipp Schubert, et al.
Cancers|September 28, 2023
Deep Learning and Registration-Based Mapping for Analyzing the Distribution of Nodal Metastases in Head and Neck Cancer Cohorts: Informing Optimal Radiotherapy Target Volume DesignThomas Weissmann, Sina Mansoorian, Matthias Stefan May, et al.
Frontiers in Oncology|December 29, 2025
Benchmarking GPT-5 in radiation oncology: measurable gains, but persistent need for expert oversightUdo S Dinc, Jibak Sarkar, Philipp Schubert, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|January 20, 2022
Low-Dose Radiotherapy Leads to a Systemic Anti-Inflammatory Shift in the Pre-Clinical K/BxN Serum Transfer Model and Reduces Osteoarthritic Pain in PatientsThomas Weissmann, Michael Rückert, Jian-Guo Zhou, et al.
Cells|February 25, 2022
Radon Improves Clinical Response in an Animal Model of Rheumatoid Arthritis Accompanied by Increased Numbers of Peripheral Blood B Cells and Interleukin-5 ConcentrationLisa Deloch, Stephanie Hehlgans, Michael Rückert, et al.
Cancers|April 3, 2021
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal CancerOliver J Ott, Cihan Gani, Lars H Lindner, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 23, 2023
Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease controlAlexander Willner, Abbas Agaimy, Katja Fechner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 5, 2023
Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects-challenges for future studiesThomas Weissmann, Michael Rückert, Florian Putz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 25, 2020
Magnetic resonance imaging for brain stereotactic radiotherapy : A review of requirements and pitfallsFlorian Putz, Veit Mengling, Rosalind Perrin, et al.
BMC Cancer|March 25, 2021
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitorsLuisa Maria Griewing, Claudia Schweizer, Philipp Schubert, et al.
Frontiers in Oncology|January 22, 2026
Correction: Benchmarking GPT-5 in radiation oncology: measurable gains, but persistent need for expert oversightUgur Dinç, Jibak Sarkar, Philipp Schubert, et al.
Cancers|September 28, 2023
Deep Learning and Registration-Based Mapping for Analyzing the Distribution of Nodal Metastases in Head and Neck Cancer Cohorts: Informing Optimal Radiotherapy Target Volume DesignThomas Weissmann, Sina Mansoorian, Matthias Stefan May, et al.
Frontiers in Oncology|December 29, 2025
Benchmarking GPT-5 in radiation oncology: measurable gains, but persistent need for expert oversightUdo S Dinc, Jibak Sarkar, Philipp Schubert, et al.
Pageof 6